Phase 2 biotech developing precision peptides for endocrine and metabolic diseases.
Industry: Health Care
Latest Trade: $23.75 0.00 (0.0%)
First Day Return: +47.8%
Return from IPO: +48.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/23/2024 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.2 |
Deal Size ($mm) | $163 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/12/2024 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.2 |
Deal Size ($mm) | $163 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Carmel, IN, United States |
Founded | 2018 |
Employees at IPO | 36 |
Website www.mbxbio.com |